(SYNC, NLS, PBH) PennyOmega.com Watch List for Tuesday Mar. 13, 2012

SYNC, Synacor, Inc. ** For the fourth quarter of 2011, SYNC posted total revenue of $28.9 million, a 59% increase year over year, and adjusted EBITDA of $2.7 million, compared to $0.5 million in the same period the prior year. SYNC’s customer-branded platform enables cable, satellite, telecom and consumer electronics companies to deliver TV Everywhere, digital entertainment, services and apps to their end-consumers, strengthening those relationships while monetizing the engagement. More about SYNC at www.synacor.com ************** * NLS, Nautilus, Inc. ** NLS reported its unaudited operating results for the fourth quarter 2011, posting net sales of $60.0 million, an increase of 11.7% year over year, and income from continuing operations of $3.3 million, compared to $1.9 million in the same period the prior year. NLS is a global fitness products company providing innovative, quality solutions to help people achieve a healthy lifestyle. With a brand portfolio including Nautilus, Bowflex, TreadClimber ,Schwinn, Schwinn Fitness, Universal and CoreBody Reformer, Nautilus markets innovative fitness products through Direct and Retail channels. More about NLS at www.nautilusinc.com ************** PBH, Prestige Brands Holdings, Inc. ** PBH reported that its Board of Directors has unanimously rejected Genomma Lab Internacional, S.A.B. de C.V.’s unsolicited, highly conditional proposal to acquire the Company for $16.60 per share, as set forth in Genomma Lab’s February 21, 2012 public letter. PBH’s Board of Directors has carefully reviewed the Genomma Lab letter with the assistance of its financial and legal advisors and, after thorough consideration in accordance with its fiduciary duties, has determined that the proposed price is inadequate and the proposal is not in the best interests of PBH and its stockholders. PBH’s Board is open to considering offers that would maximize value for stockholders and minimize disruption while the Company is integrating its recent acquisitions. Accordingly, the Board has taken steps to resolve the uncertainty created by Genomma Lab’s unsolicited proposal quickly and in the best interests of all stakeholders, including implementing a short-term shareholder rights plan and scheduling an earlier annual meeting. PBH markets and distributes brand name over-the-counter and household cleaning products throughout the U.S., Canada, and certain international markets. More about PBH at www.prestigebrandsinc.com ******************************** THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOmega.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyomega.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.